Imricor Medical Systems, Inc.

Imricor Medical Systems, Inc. is a healthcare technology company specializing in the development of advanced medical devices for cardiac ablation procedures. The company's primary focus is on creating MRI-compatible systems that enable real-time magnetic resonance imaging–guided cardiac catheter ablation, a significant innovation intended to address limitations associated with conventional X-ray-guided procedures. Imricor’s notable products include the Vision-MR Ablation Catheter, the Advantage-MR EP Recorder/Stimulator system, and the Vision-MR Dispersive Electrode, all designed for use in interventional cardiac magnetic resonance (iCMR) laboratories. These products aim to improve the precision, efficacy, and safety of treatments for cardiac arrhythmias, particularly atrial flutter, by allowing direct visualization of cardiac tissue during ablation. Imricor’s technology is recognized for its potential to increase procedural success rates, reduce patient exposure to radiation, and optimize overall treatment costs. Founded in 2006 and based in Burnsville, Minnesota, Imricor serves hospitals and clinics internationally, generating the most revenue from Europe, with growing presence in the Middle East and the United States. The company plays a pivotal role in advancing minimally invasive cardiac interventions within the global medical devices sector.